Zsigo J[au] - Search Results

Year	Number of Results
1985	1
1989	2
1990	1
1991	1
1992	2
1993	2
1997	1
2023	0

1

Potent agonists of growth hormone-releasing hormone. Part I.

Zarandi M, Serfozo P, Zsigo J, Bokser L, Janaky T, Olsen DB, Bajusz S, Schally AV. Zarandi M, et al. Among authors: zsigo j. Int J Pept Protein Res. 1992 Mar;39(3):211-7. doi: 10.1111/j.1399-3011.1992.tb00791.x. Int J Pept Protein Res. 1992. PMID: 1399259

2

Development of a radioimmunoassay for some agonists of growth hormone-releasing hormone.

Groot K, Csernus VJ, Pinski J, Zsigo J, Rekasi Z, Zarandi M, Schally AV. Groot K, et al. Among authors: zsigo j. Int J Pept Protein Res. 1993 Feb;41(2):162-8. doi: 10.1111/j.1399-3011.1993.tb00127.x. Int J Pept Protein Res. 1993. PMID: 8458690

3

Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist.

Kojro E, Hackenberg M, Zsigo J, Fahrenholz F. Kojro E, et al. Among authors: zsigo j. J Biol Chem. 1991 Nov 15;266(32):21416-21. J Biol Chem. 1991. PMID: 1657965 Free article.

4

Structure-activity relationships of a series of [D-Ala2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability.

Thomas SA, Abbruscato TJ, Hau VS, Gillespie TJ, Zsigo J, Hruby VJ, Davis TP. Thomas SA, et al. Among authors: zsigo j. J Pharmacol Exp Ther. 1997 May;281(2):817-25. J Pharmacol Exp Ther. 1997. PMID: 9152390

5

The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature.

Jans DA, Peters R, Zsigo J, Fahrenholz F. Jans DA, et al. Among authors: zsigo j. EMBO J. 1989 Sep;8(9):2481-8. doi: 10.1002/j.1460-2075.1989.tb08384.x. EMBO J. 1989. PMID: 2531084 Free PMC article.

6

In vivo sulfation of cholecystokinin octapeptide. Possible interactions of the two forms of cholecystokinin with dopamine in the brain.

Penke B, Kovács GL, Zsigó J, Kádár T, Szabó G, Kovács K, Telegdy G. Penke B, et al. Among authors: zsigo j. Ann N Y Acad Sci. 1985;448:293-305. doi: 10.1111/j.1749-6632.1985.tb29925.x. Ann N Y Acad Sci. 1985. PMID: 2862826

7

Potent agonists of growth hormone-releasing hormone. II.

Zarandi M, Serfozo P, Zsigo J, Deutch AH, Janaky T, Olsen DB, Bajusz S, Schally AV. Zarandi M, et al. Among authors: zsigo j. Pept Res. 1992 Jul-Aug;5(4):190-3. Pept Res. 1992. PMID: 1421808

8

Comparison of GH-stimulation by GH-RH(1-29)NH2 and an agmatine29 GH-RH analog, after intravenous, subcutaneous and intranasal administration and after pulmonary inhalation in rats.

Pinski J, Yano T, Groot K, Zsigo J, Rekasi Z, Comaru-Schally AM, Schally AV. Pinski J, et al. Among authors: zsigo j. Int J Pept Protein Res. 1993 Mar;41(3):246-9. doi: 10.1111/j.1399-3011.1993.tb00332.x. Int J Pept Protein Res. 1993. PMID: 8463048

9

Somatostatin28(15-28), but not somatostatin28(1-12), affects central monoaminergic neurotransmission in rats.

Vécsei L, Widerlöv E, Alling C, Zsigó J, Pávó I, Penke B. Vécsei L, et al. Among authors: zsigo j. Neuropeptides. 1990 Aug;16(4):181-6. doi: 10.1016/0143-4179(90)90060-c. Neuropeptides. 1990. PMID: 1703283

10

Comparative studies of somatostatin-14 and some of its fragments on passive avoidance behavior, open field activity and on barrel rotation phenomenon in rats.

Vécsei L, Pavo I, Zsigo J, Penke B, Widerlöv E. Vécsei L, et al. Among authors: zsigo j. Peptides. 1989 Nov-Dec;10(6):1153-7. doi: 10.1016/0196-9781(89)90007-7. Peptides. 1989. PMID: 2576124

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results